GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kissei Pharmaceutical Co Ltd (TSE:4547) » Definitions » Median PS Value

Kissei Pharmaceutical Co (TSE:4547) Median PS Value : 円3,011.17 (As of May. 12, 2024)


View and export this data going back to 1988. Start your Free Trial

What is Kissei Pharmaceutical Co Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Kissei Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円1670.441. Kissei Pharmaceutical Co's 10-Year median PS Ratio is 1.8026. Therefore, the Median PS Value for today is 円3,011.17.

As of today (2024-05-12), Kissei Pharmaceutical Co's share price is 円3185.00. Kissei Pharmaceutical Co's Median PS Value is 円3,011.17. Therefore, Kissei Pharmaceutical Co's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Kissei Pharmaceutical Co's Median PS Value or its related term are showing as below:

During the past 13 years, the highest Price to Median PS Value of Kissei Pharmaceutical Co was 1.14. The lowest was 0.91. And the median was 0.99.

TSE:4547's Price-to-Median-PS-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.87
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Kissei Pharmaceutical Co Median PS Value Historical Data

The historical data trend for Kissei Pharmaceutical Co's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kissei Pharmaceutical Co Median PS Value Chart

Kissei Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,437.27 2,681.82 2,569.97 2,678.01 -

Kissei Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,678.01 2,828.34 2,893.52 3,011.17 -

Competitive Comparison of Kissei Pharmaceutical Co's Median PS Value

For the Drug Manufacturers - Specialty & Generic subindustry, Kissei Pharmaceutical Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kissei Pharmaceutical Co's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kissei Pharmaceutical Co's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Kissei Pharmaceutical Co's Price-to-Median-PS-Value falls into.



Kissei Pharmaceutical Co Median PS Value Calculation

Kissei Pharmaceutical Co's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=1670.441*1.8026
=3,011.17

10-Year Median PS Ratio is 1.8026.
Kissei Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1670.441.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kissei Pharmaceutical Co  (TSE:4547) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Kissei Pharmaceutical Co's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=3185.00/3,011.17
=1.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kissei Pharmaceutical Co Median PS Value Related Terms

Thank you for viewing the detailed overview of Kissei Pharmaceutical Co's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Kissei Pharmaceutical Co (TSE:4547) Business Description

Traded in Other Exchanges
Address
19-48, Yoshino, Matsumoto City, Nagano, JPN, 399-8710
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kissei Pharmaceutical Co (TSE:4547) Headlines

No Headlines